Mona from Calgary asks: I don’t see anything about Rinvoq. My rheumatologist has suggested that one for me.
Rinvoq, otherwise known as Upadacitinib, is part of a newer class of advanced disease modifying medications for inflammatory arthritis called JAK Kinase inhibitors. To learn more about it and the other JAK Kinase inhibitors that are currently available, visit our webpage here.
Posted: August 11, 2022
Tagged: DMARD, JAK, rheumatoid arthritis